Cargando…
Gene Therapy Targeting HIV Entry
Despite the unquestionable success of antiretroviral therapy (ART) in the treatment of HIV infection, the cost, need for daily adherence, and HIV-associated morbidities that persist despite ART all underscore the need to develop a cure for HIV. The cure achieved following an allogeneic hematopoietic...
Autores principales: | Didigu, Chuka, Doms, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970157/ https://www.ncbi.nlm.nih.gov/pubmed/24662607 http://dx.doi.org/10.3390/v6031395 |
Ejemplares similares
-
Novel Approaches to Inhibit HIV Entry
por: Didigu, Chukwuka A., et al.
Publicado: (2012) -
HIV-1 Membrane Fusion: Targets of Opportunity
por: Doms, Robert W., et al.
Publicado: (2000) -
Dengue Virus Entry as Target for Antiviral Therapy
por: Alen, Marijke M. F., et al.
Publicado: (2012) -
HIV Transmission: Closing All the Doors
por: Davis, Carl W., et al.
Publicado: (2004) -
Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket
por: Yu, Fei, et al.
Publicado: (2013)